A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury (2022)
- Authors:
- USP affiliated authors: FERREIRA, JULIO CESAR BATISTA - ICB ; CAMPOS, JULIANE CRUZ - ICB
- Unidade: ICB
- DOI: 10.3390/ph15030271
- Subjects: ANATOMIA; ISQUEMIA MIOCÁRDICA; TROPONINA I; PROTEÍNAS MUSCULARES; PEPTÍDEOS; INFARTO DO MIOCÁRDIO; CARDIOPATIAS; AMINOÁCIDOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Pharmaceuticals
- ISSN: 1424-8247
- Volume/Número/Paginação/Ano: v. 15, n. 3, art. 271, p. 1-11, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
QVIT, Nir et al. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury. Pharmaceuticals, v. 15, n. 3, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15030271. Acesso em: 19 abr. 2024. -
APA
Qvit, N., Lin, A. J., Elezaby, A., Ostberg, N. P., Campos, J. C., Ferreira, J. C. B., & Rosen, D. M. (2022). A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury. Pharmaceuticals, 15( 3), 1-11. doi:10.3390/ph15030271 -
NLM
Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Rosen DM. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury [Internet]. Pharmaceuticals. 2022 ; 15( 3): 1-11.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3390/ph15030271 -
Vancouver
Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Rosen DM. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury [Internet]. Pharmaceuticals. 2022 ; 15( 3): 1-11.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3390/ph15030271 - Mild mitochondrial impairment enhances innate immunity and longevity through ATFS-1 and p38 signaling
- Comment on: “Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients” by Etienne et al.
- Mitophagy protects against statin-mediated skeletal muscle toxicity
- β2-Adrenergic signaling modulates mitochondrial function and morphology in skeletal muscle in response to aerobic exercise
- Mitochondrial unfolded protein response (UPRmt) activation in cardiac diseases: opportunities and challenges
- Controle de qualidade de proteína na disfunção/atrofia muscular esquelética: papel do receptor β-adrenérgico
- Caracterização da função e da dinâmica mitocondrial em modelo animal de disfunção cardíaca associada ao infarto do miocárdio: efeitos do treinamento físico aeróbico
- In vivo measurement of aldehyde dehydrogenase-2 activity in rat liver ethanol model using dynamic MRSI of hyperpolarized [1-13C]pyruvate
- Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury
- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death
Informações sobre o DOI: 10.3390/ph15030271 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | A Selective Inhibitor of ... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
